🇺🇸 FDA
Patent

US 10869865

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

granted A61KA61K31/42A61K31/422

Quick answer

US patent 10869865 (Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria) held by The United States of America, as represented by the Secretary, Department of Health and Human Serv expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Serv
Grant date
Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/42, A61K31/422, A61K31/423, A61K31/427